Boothbay Fund Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Buy |
+6,896
| New | +$1.66M | 0.03% | 404 |
|
|
2024
Q4 | – | Sell |
-872
| Closed | -$292K | – | 1341 |
|
|
2024
Q3 | $292K | Sell |
872
-69
| -7% | -$23.1K | 0.01% | 1082 |
|
|
2024
Q2 | $257K | Buy |
+941
| New | +$257K | 0.01% | 1064 |
|
|
2023
Q2 | – | Sell |
-588
| Closed | -$282K | – | 1595 |
|
|
2023
Q1 | $282K | Buy |
+588
| New | +$282K | 0.01% | 1324 |
|
|
2022
Q4 | – | Sell |
-780
| Closed | -$325K | – | 1753 |
|
|
2022
Q3 | $325K | Buy |
+780
| New | +$325K | 0.01% | 1266 |
|
|
2022
Q2 | – | Sell |
-466
| Closed | -$262K | – | 1982 |
|
|
2022
Q1 | $262K | Buy |
+466
| New | +$262K | 0.01% | 1339 |
|
|
2021
Q4 | – | Sell |
-373
| Closed | -$278K | – | 1694 |
|
|
2021
Q3 | $278K | Buy |
+373
| New | +$278K | 0.01% | 1147 |
|